BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5516947)

  • 1. [Prevention of recurrence of gastric and duodenal ulcer by methyluracil therapy in industrial plants].
    Svistunova IA
    Sov Med; 1970 Dec; 33(12):58-62. PubMed ID: 5516947
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of preventive sanatoriums at industrial plants in the prevention of the exacerbation (recurrence) of peptic ulcer and lowering of temporary work disability].
    Krivitskiĭ AA; Matiukha SI; Kovrova AA; Levenets GG
    Vrach Delo; 1971 Mar; 3():154-6. PubMed ID: 5578006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of pyrimidine derivatives (pentoxyl and 4-methyluracil) in peptic ulcer therapy].
    Levin AI; Tsimmerman IaS; Nikolaĭchik NA
    Sov Med; 1969 Nov; 32(11):81-4. PubMed ID: 5382903
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment to prevent recurrence of gastric and duodenal ulcers in industrial conditions].
    Lomazova MM
    Vrach Delo; 1972 Jul; 7():98-9. PubMed ID: 5083773
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complex therapy of peptic ulcer including methyluracil].
    Levin AI; Tsimmerman IaS; Ikorskaia RV
    Vrach Delo; 1969 Apr; 4():11-4. PubMed ID: 5373579
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vitamin B1 therapy in gastric and duodenal ulcer].
    IVANOV-NEZNAMOV VI
    Klin Med (Mosk); 1958 Jan; 36(1):133-9. PubMed ID: 13550577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Application of methyluracil in the complex treatment of peptic ulcer].
    Kapitanenko AM
    Voen Med Zh; 1970 Apr; 4():48-50. PubMed ID: 5430629
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of disability in gastric and duodenal peptic ulcer].
    Nasybullina MA
    Med Sestra; 1979 Feb; 38(2):14-7. PubMed ID: 254827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical role of methyluracil in combined treatment of patients with peptic ulcer].
    Asauliuk IK; Zhdan PP
    Vrach Delo; 1983 Jul; (7):32-5. PubMed ID: 6624053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with an internal treatment method in inflammatory and ulcerative disorders of the gastric and intestinal mucosa].
    Zwerenz G
    Landarzt; 1967 Oct; 43(29):1431-3. PubMed ID: 5612658
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of peptic ulcer with methyluracil].
    Agapova EN; Krutovskaia OV; Afaunova VI; Nikolaeva SA
    Vrach Delo; 1974 Jan; (1):74-6. PubMed ID: 4468587
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of dispensary service in the treatment of gastric and duodenal ulcer].
    Kalashnogo GV
    Vrach Delo; 1969; 12():115-6. PubMed ID: 5375606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of gastric and duodenal ulcers with histidine and vitamin C combination].
    BORGHI B
    Omnia Med Suppl; 1955; 6(4):377-90. PubMed ID: 13309953
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of methyluracil in the complex treatment of peptic ulcer].
    Asayliuk IK; Zhdan PP
    Vrach Delo; 1980 Mar; (3):24-6. PubMed ID: 7376604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methyluracil treatment effectiveness in peptic ulcer].
    Gil'fer II
    Vrach Delo; 1981 May; (5):38-40. PubMed ID: 7257260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic action of nucleic acid-synthesis stimulants in peptic ulcer].
    Deĭneko NF; Ikhnenko RI; Zviagintseva TD; Shustval' NF; Shevela VV
    Vrach Delo; 1980 Oct; (10):70-2. PubMed ID: 6159727
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
    Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.